borderline significantp = 0.064
Notably, the SFCT at 12 months post-treatment showed borderline significant effect on the final BCVA ( p = 0.064, Table 3 ).
Notably, the SFCT at 12 months post-treatment showed borderline significant effect on the final BCVA ( p = 0.064, Table 3 ).